Your browser doesn't support javascript.
loading
Nutritional Status at Diagnosis, During, and After Treatment in Adolescents and Young Adults with Cancer.
van der Haak, Natalie; Edwards, Suzanne; Perem, Merike; Landorf, Emma; Osborn, Michael.
Affiliation
  • van der Haak N; Department of Nutrition, Women's and Children's Hospital, North Adelaide, South Australia.
  • Edwards S; Adelaide Health Technology Assessment, Data, Design and Statistics Service, School of Public Health, The University of Adelaide, Adelaide, South Australia.
  • Perem M; Youth Cancer Service, Royal Adelaide Hospital, Adelaide, South Australia.
  • Landorf E; Department of Nutrition, Women's and Children's Hospital, North Adelaide, South Australia.
  • Osborn M; Youth Cancer Service, Royal Adelaide Hospital, Adelaide, South Australia.
J Adolesc Young Adult Oncol ; 10(6): 668-674, 2021 12.
Article in En | MEDLINE | ID: mdl-33844931
Purpose: Malnutrition is commonly observed during cancer treatment, while some cancer survivors are at risk of overweight and obesity. This study investigated nutritional status during and after treatment in adolescents and young adults (AYA) with cancer. Methods: A retrospective chart review of AYA diagnosed with cancer was conducted. Data were collected monthly during treatment, then annually for 3 years of follow-up. Results: Of 93 AYA, 8% were underweight at diagnosis versus 20% during treatment (p = 0.012). Forty-four percent experienced ≥5% loss of weight (LOW) during treatment, and 23% of those were not referred to a dietitian. While 47% were referred to a dietitian at some point during treatment, 77% did not have dietetic involvement in the month after reaching greatest percentage LOW. Different tumor types were associated with different risks of LOW. Eighty-six percent with acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LL) and 86% with acute myeloid leukemia had ≥5% LOW during treatment, compared with 17% with Hodgkin lymphoma (p < 0.0001). In year 3 of follow-up, 36% of all AYA were overweight or obese versus 25% at diagnosis (p = 0.2). Overweight/obesity was more common in ALL/LL survivors than other tumor types (67% vs. 14%, p = 0.037). No patients had dietitian involvement in year 3 of follow-up. Conclusions: AYA, particularly those with ALL/LL, are at risk of significant weight loss during treatment and overweight and obesity during survivorship. Dietetic involvement was inconsistent in this cohort. These data may guide which diagnoses warrant preemptive dietetic input during treatment and highlight the importance of dietetic involvement in survivorship.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Trofoterapia Main subject: Hodgkin Disease / Cancer Survivors Type of study: Diagnostic_studies / Observational_studies Language: En Journal: J Adolesc Young Adult Oncol Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Trofoterapia Main subject: Hodgkin Disease / Cancer Survivors Type of study: Diagnostic_studies / Observational_studies Language: En Journal: J Adolesc Young Adult Oncol Year: 2021 Type: Article